At an annual shareholders meeting new Medtronic CEO says that betting on an emerging middle class in developing countries could be less risky than pouring money into research and development for the flat U.S. market. Targeting the growing middle class in China, India and other emerging countries may be "potentially less risky than creating new products for the flat U.S market," new Medtronic Inc. (NYSE:MDT) CEO Omar Ishrak said in his first shareholders meeting today.
